IKBKE and breast carcinoma: Since IKKε has been shown to be an oncogene in different breast cancer subtypes (Boehm et al, 2007), we used T47D and MDA‐MB‐468 cell lines to model estrogen receptor positive (ER+) and triple‐negative breast cancer, respectively (Subik et al, 2010).